Skip to main content

BENDAMUSTINE HYDROCHLORIDE

NDC 10019-079 · Baxter Healthcare Corporation

Generic namebendamustine hydrochloride
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)BENDAMUSTINE HYDROCHLORIDE
Strength100 mg/1
Pharmacologic classAlkylating Activity [MoA], Alkylating Drug [EPC]
Marketing categoryNDA

Packages

10019-079-01 — 1 VIAL, MULTI-DOSE in 1 CARTON (10019-079-01) / 1 INJECTION in 1 VIAL, MULTI-DOSE

Billed under HCPCS

J9036 — Injection, bendamustine hydrochloride, (belrapzo/bendamustine), 1 mg Medicare Part B payment limit (ASP + 6%): $11.60

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

16729-250 — bendamustine hydrochloride, 16729-251 — bendamustine hydrochloride, 24338-270 — BENDAMUSTINE HYDROCHLORIDE, 42367-521 — bendamustine hydrochloride, 55150-391 — BENDAMUSTINE HYDROCHLORIDE, 55150-392 — BENDAMUSTINE HYDROCHLORIDE, 60505-6228 — Bendamustine Hydrochloride, 63459-348 — bendamustine hydrochloride, 63459-390 — Bendamustine Hydrochloride, 63459-391 — Bendamustine Hydrochloride, 68001-572 — bendamustine hydrochloride, 71225-120 — BENDAMUSTINE HYDROCHLORIDE, 71288-102 — bendamustine HCl, 71288-103 — Bendamustine HCl, 83831-183 — bendamustine hydrochloride

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.